Notícias Mainz BioMed NV - MYNZ | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Mainz BioMed NV (MYNZ)
Mainz BioMed NV (MYNZ) Notícias

Mainz BioMed NV (MYNZ)

5,9678

1,20

( 25,11% )

Atualizado: 13:07:15

Atrasado por 15 minutos

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form EFFECT - Notice of Effectiveness

Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules

Silexion Is Addressing the MOST COMMON Human Cancer Gene Mutation With RNAi; Recent M&As in the Field Were for Tens of Billions - $SLXN

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Mainz Biomed Announces Stock Split

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Mainz BioMed NV

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições